Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China.
Saved in:
| Title: | Immune recovery following switch from EFV-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed immunological non-responders: a 144-week real-world cohort study in China. |
|---|---|
| Authors: | Yang H; Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China., Yu Q; Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China., Li M; Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China., Liu M; Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 09; Vol. 17, pp. 1862837. Date of Electronic Publication: 2026 Jun 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1862837 |
